Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017

Alexandra Albertsson Lindblad; Thorgerdur Palsdottir; Karin E Smedby; Caroline E Weibull; Ingrid Glimelius; Mats Jerkeman

doi:10.3324/haematol.2021.279037

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017

Alexandra Albertsson Lindblad, Thorgerdur Palsdottir, Karin E Smedby, Caroline E Weibull, Ingrid Glimelius, Mats Jerkeman

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	740-743
Journal	Haematologica
Volume	107
Issue number	3
DOIs	https://doi.org/10.3324/haematol.2021.279037
Publication status	Published - 2022

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3324/haematol.2021.279037Licence: Unspecified

Cite this

@article{801972e60d9c4795b106d097f804434b,

title = "Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017",

author = "{Albertsson Lindblad}, Alexandra and Thorgerdur Palsdottir and Smedby, {Karin E} and Weibull, {Caroline E} and Ingrid Glimelius and Mats Jerkeman",

year = "2022",

doi = "10.3324/haematol.2021.279037",

language = "English",

volume = "107",

pages = "740--743",

journal = "Haematologica",

issn = "1592-8721",

publisher = "Ferrata Storti Foundation",

number = "3",

}

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017. / Albertsson Lindblad, Alexandra; Palsdottir, Thorgerdur; Smedby, Karin E et al.
In: Haematologica, Vol. 107, No. 3, 2022, p. 740-743.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017

AU - Albertsson Lindblad, Alexandra

AU - Palsdottir, Thorgerdur

AU - Smedby, Karin E

AU - Weibull, Caroline E

AU - Glimelius, Ingrid

AU - Jerkeman, Mats

PY - 2022

Y1 - 2022

U2 - 10.3324/haematol.2021.279037

DO - 10.3324/haematol.2021.279037

M3 - Letter

C2 - 34788983

SN - 1592-8721

VL - 107

SP - 740

EP - 743

JO - Haematologica

JF - Haematologica

IS - 3

ER -